Browsing Tag
Biopharmaceutical Industry
9 posts
CIMG Inc acquisition of Daren Business Technology signals a strategic pivot toward biopharmaceutical scale ambitions
CIMG Inc is entering biopharmaceuticals with a $40 million, performance-linked acquisition. Find out what this deal means for strategy, risk, and investors.
AbbVie strengthens U.S. manufacturing strategy with Arizona facility deal, reinforcing long-term supply resilience
Find out how AbbVie’s Arizona manufacturing acquisition strengthens U.S. drug production and reinforces long-term supply resilience.
Atai Life Sciences acquires exclusive rights to Psilera’s DMT patent portfolio
Atai Life Sciences has taken a strategic step in expanding its position in psychedelic medicine by securing exclusive…
Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing…
Ascentage Pharma receives $100m payment from Takeda under exclusive option agreement
Ascentage Pharma, a leading global biopharmaceutical company specializing in novel therapies for cancer and other serious diseases, has…
Ovid Therapeutics announces significant workforce reduction to extend cash runway
Ovid Therapeutics Inc., a New York-based biopharmaceutical company, has announced a significant reduction in its workforce. This decision,…
Cycle Pharmaceuticals proposes $466m acquisition of Vanda Pharmaceuticals
In a significant development within the pharmaceutical industry, UK-based Cycle Pharmaceuticals has offered to acquire Nasdaq-listed Vanda Pharmaceuticals…
Roche to strengthen gene therapy portfolio with Spark Therapeutics acquisition
Swiss pharmaceutical giant Roche has reached a major agreement to acquire the U.S.-based gene therapy company Spark Therapeutics…
PTC Therapeutics completes $200m acquisition of Agilis Biotherapeutics to expand gene therapy portfolio
In a major strategic move, US biopharmaceutical company PTC Therapeutics has finalized its acquisition of Agilis Biotherapeutics, a…